1. Bo, Wentao, Feng, Xielin, Tang, Xiaoli. 2020. Overexpression of rhophilin 2 promotes pancreatic ductal adenocarcinoma. In Oncology letters, 21, 76. doi:10.3892/ol.2020.12337. https://pubmed.ncbi.nlm.nih.gov/33365087/
2. Yu, Fengsheng, Qiao, Pingping, Yin, Guangjie, Chu, Yijing, Wang, Yankui. 2020. RHPN2 Promotes Malignant Cell Behaviours in Ovarian Cancer by Activating STAT3 Signalling. In OncoTargets and therapy, 13, 11517-11527. doi:10.2147/OTT.S272752. https://pubmed.ncbi.nlm.nih.gov/33204106/
3. Liu, Z, Fang, F, Li, J, Zhang, F, Die, J. . [RHPN2 is highly expressed in osteosarcoma cells to promote cell proliferation and migration and inhibit apoptosis]. In Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 42, 1367-1373. doi:10.12122/j.issn.1673-4254.2022.09.13. https://pubmed.ncbi.nlm.nih.gov/36210710/
4. Yin, Lu, Zhang, Zhanshuo, Yan, Zhu, Yan, Qiuyue. 2024. Multicenter cohort analysis of anoikis and EMT: implications for prognosis and therapy in lung adenocarcinoma. In Discover oncology, 15, 462. doi:10.1007/s12672-024-01293-6. https://pubmed.ncbi.nlm.nih.gov/39298078/
5. Chen, Chunyu, Guo, Qiang, Shi, Jinna, Hui, Xiang, Song, Tao. 2018. Genetic variants of MGMT, RHPN2, and FAM49A contributed to susceptibility of nonsyndromic orofacial clefts in a Chinese population. In Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 47, 796-801. doi:10.1111/jop.12758. https://pubmed.ncbi.nlm.nih.gov/29949196/
智鼠故事 
